TrialThe Journal of thoracic and cardiovascular surgery2022

Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.

Boris Sepesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.